Intelligence / Healthtech / New Clinical Trials / Sleep Cycle AB
Clinicaltrial registered18 Nov 2026
Sleep Cycle AB
18 Nov 2026: Trial registered · Development of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep Behaviors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 18 Nov 2026
- Title
- Development of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep Behaviors
- Conditions
- Sleep Apnea, Obstructive
- Study Type
- Observational
- Status
- Completed
- Countries
- Australia
- Country
- Australia
- Reference
- NCT07947017
- Location
- Australia
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Sleep Cycle AB
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Australia
New Clinical Trials
18 NovChengdu Zenitar Biomedical Technology Co., Ltdtrial registered · A Phase I Clinical Study of Oral ZL-65 Tablets in Healthy and Obese Participants With Cardiovascular RiskClinical18 NovShanghai Henlius Biotechtrial registered · A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX49 in Advanced/Metastatic Solid TumorsClinical17 NovAerys Biosciencestrial registered · First-in-Human Study of ABS-169 in Healthy VolunteersClinical17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical17 NovNS Pharma, Inc.trial registered · A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyClinical16 NovCStone Pharmaceuticalstrial registered · A First-in-human (FIH), Open-label, and Multi-center Study of CS5006 in Participants With Advanced Solid TumorsClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.